Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics Market Cap : 104.18M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 104.18M |
| September 24, 2026 | 106.67M |
| September 23, 2026 | 106.67M |
| September 22, 2026 | 107.17M |
| September 21, 2026 | 106.67M |
| September 18, 2026 | 101.69M |
| September 17, 2026 | 106.67M |
| September 16, 2026 | 101.19M |
| September 15, 2026 | 101.94M |
| September 14, 2026 | 100.69M |
| September 11, 2026 | 100.19M |
| September 10, 2026 | 99.19M |
| September 09, 2026 | 103.68M |
| September 08, 2026 | 100.69M |
| September 04, 2026 | 99.69M |
| September 03, 2026 | 99.19M |
| September 02, 2026 | 101.69M |
| September 01, 2026 | 98.70M |
| August 31, 2026 | 100.19M |
| August 28, 2026 | 102.68M |
| August 27, 2026 | 105.18M |
| August 26, 2026 | 104.18M |
| August 25, 2026 | 99.19M |
| August 24, 2026 | 93.21M |
| August 21, 2026 | 103.18M |
| Date | Value |
|---|---|
| August 20, 2026 | 106.67M |
| August 19, 2026 | 107.67M |
| August 18, 2026 | 104.18M |
| August 17, 2026 | 104.68M |
| August 14, 2026 | 129.60M |
| August 13, 2026 | 124.62M |
| August 12, 2026 | 111.16M |
| August 11, 2026 | 109.66M |
| August 10, 2026 | 100.37M |
| August 07, 2026 | 107.00M |
| August 06, 2026 | 105.10M |
| August 05, 2026 | 106.05M |
| August 04, 2026 | 105.58M |
| August 03, 2026 | 103.68M |
| July 31, 2026 | 109.36M |
| July 30, 2026 | 101.79M |
| July 29, 2026 | 94.21M |
| July 28, 2026 | 94.21M |
| July 27, 2026 | 92.79M |
| July 24, 2026 | 97.05M |
| July 23, 2026 | 99.89M |
| July 22, 2026 | 106.05M |
| July 21, 2026 | 109.84M |
| July 20, 2026 | 107.00M |
| July 17, 2026 | 107.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 16.13M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0814M |
| Arvinas, Inc. | 495.63M |
| Fulcrum Therapeutics, Inc. | 285.31M |
Market Cap Related Metrics
| Price to Book Value | 9.523 |
| Price | 2.09 |
| Earnings Yield | -6.90% |